Clinical Trial Update: Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL) [Phase 2]

View source ↗

Summary

This clinical trial update notes withdrawal of a Phase 2 study evaluating adding targeted drugs to standard chemotherapy for adults with newly diagnosed T-cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma | Phase 2 | Status: WITHDRAWN